GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,019,721 | -26.7% | 302,512 | -12.1% | 0.17% | -18.7% |
| Q2 2023 | $20,482,713 | +106028.0% | 344,016 | +1.0% | 0.21% | +2.9% |
| Q1 2023 | $19,300 | -23.7% | 340,762 | -0.0% | 0.21% | -26.2% |
| Q4 2022 | $25,308 | -99.9% | 340,764 | -17.2% | 0.28% | -3.4% |
| Q3 2022 | $24,531,000 | +22.0% | 411,775 | +15.0% | 0.29% | +29.2% |
| Q2 2022 | $20,102,000 | -7.8% | 358,046 | +21.1% | 0.23% | +8.1% |
| Q1 2022 | $21,807,000 | +2.5% | 295,584 | +0.3% | 0.21% | +6.1% |
| Q4 2021 | $21,272,000 | -48.3% | 294,660 | -45.1% | 0.20% | -0.5% |
| Q3 2021 | $41,114,000 | +101.4% | 536,628 | +103.8% | 0.20% | 0.0% |
| Q2 2021 | $20,416,000 | +35.2% | 263,334 | +7.6% | 0.20% | +32.9% |
| Q1 2021 | $15,099,000 | -17.3% | 244,765 | -12.6% | 0.15% | -26.6% |
| Q4 2020 | $18,262,000 | +35.3% | 279,987 | +2.7% | 0.20% | +10.9% |
| Q3 2020 | $13,494,000 | +82.5% | 272,502 | +75.9% | 0.18% | +47.6% |
| Q2 2020 | $7,394,000 | +1.8% | 154,947 | -9.2% | 0.12% | -16.2% |
| Q1 2020 | $7,261,000 | -11.1% | 170,707 | +23.0% | 0.15% | +16.5% |
| Q4 2019 | $8,171,000 | -0.8% | 138,762 | -13.9% | 0.13% | -0.8% |
| Q3 2019 | $8,239,000 | +16.3% | 161,197 | -3.9% | 0.13% | +19.6% |
| Q2 2019 | $7,087,000 | -4.0% | 167,694 | +12.2% | 0.11% | -7.0% |
| Q1 2019 | $7,383,000 | +4.9% | 149,446 | -8.1% | 0.12% | -5.0% |
| Q4 2018 | $7,041,000 | -25.6% | 162,674 | -2.4% | 0.12% | -12.9% |
| Q3 2018 | $9,459,000 | +7.3% | 166,644 | -4.6% | 0.14% | +3.7% |
| Q2 2018 | $8,817,000 | -26.9% | 174,742 | -27.8% | 0.13% | -52.0% |
| Q1 2018 | $12,058,000 | -13.2% | 242,039 | -28.4% | 0.28% | -8.8% |
| Q4 2017 | $13,891,000 | +46.2% | 337,969 | +5.7% | 0.31% | +38.5% |
| Q3 2017 | $9,500,000 | -11.7% | 319,654 | -1.5% | 0.22% | -13.0% |
| Q2 2017 | $10,762,000 | +10.9% | 324,647 | -0.9% | 0.25% | +8.1% |
| Q1 2017 | $9,705,000 | +5.9% | 327,652 | -11.3% | 0.24% | +2.2% |
| Q4 2016 | $9,165,000 | -19.3% | 369,416 | -26.5% | 0.23% | -21.0% |
| Q3 2016 | $11,351,000 | -5.9% | 502,916 | -0.6% | 0.29% | -8.5% |
| Q2 2016 | $12,059,000 | -39.0% | 506,053 | -39.3% | 0.32% | -35.1% |
| Q1 2016 | $19,784,000 | -29.2% | 833,029 | -17.1% | 0.49% | -27.1% |
| Q4 2015 | $27,943,000 | +29.6% | 1,004,414 | -3.7% | 0.67% | +28.0% |
| Q3 2015 | $21,557,000 | -20.5% | 1,043,406 | -1.2% | 0.52% | -13.5% |
| Q2 2015 | $27,119,000 | +11.3% | 1,056,441 | +9.4% | 0.61% | +10.8% |
| Q1 2015 | $24,369,000 | +10.9% | 965,475 | +4.5% | 0.55% | +10.5% |
| Q4 2014 | $21,966,000 | +18.8% | 924,097 | -1.7% | 0.50% | +16.2% |
| Q3 2014 | $18,489,000 | +60.8% | 939,947 | +95.5% | 0.43% | +55.8% |
| Q2 2014 | $11,498,000 | -57.1% | 480,680 | -52.3% | 0.27% | -14.4% |
| Q1 2014 | $26,780,000 | +42.3% | 1,007,122 | +8.0% | 0.32% | +44.8% |
| Q4 2013 | $18,814,000 | – | 932,342 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |